Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5361-5371

  Ozaki, Katsutoshi ^a,f   Spolski, Rosanne ^a   Ettinger, Rachel ^b   Kim, Hyoung Fyo ^a   Wang, Gang ^c,g   Qi, Chen Feng ^d   Hwu, Patrick ^c,g   Shaffer, Daniel J ^e   Akilesh, Shreeram ^e   Roopenian, Derry C ^e   Morse III, Herbert C ^d   Lipsky, Peter E ^b   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e JACKSON LABORATORY   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN G1; INTERLEUKIN 21; INTERLEUKIN 4; PLASMID DNA; PROTEIN BCL 6; PROTEIN BLIMP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL FATE; CELL LINEAGE; CONTROLLED STUDY; GENE DELIVERY SYSTEM; HYDRODYNAMICS; IMMUNOGLOBULIN PRODUCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSGENIC MOUSE; WILD TYPE;

EID: 6344269331     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5361     Document Type: Article

References (33)

1. Ozaki, K., K. Kikly, D. Michalovich, P. R. Young, and W. J. Leonard. 2000. Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc. Natl. Acad. Sci. USA 97:11439.
2. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57.
3. Leonard, W. J. 2001. Cytokines and immunodeficiency diseases. Nat. Rev. Immunol. 1:200.
4. Asao, H., H. C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura. 2001. The common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167:1.
5. Kasaian, M. T., M. J. Whitters, L. L. Carter, L. D. Lowe, J. M Jussif, B. Deng, K. A. Johnson, J. S. Witek, M. Senices, R. F. Konz, et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16:559.
6. Ozaki, K., R. Spolski, C. G. Feng, J. Cheng, A. Sher, C. Liu, P. L. Schwarzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298:1630.
7. Suto, A., H. Nakajima, K. Hirose, K. Suzuki, S. Kagami, Y. Seto, A. Hoshimoto, Y. Saito, D. C. Foster, and I. Iwamoto. 2002. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4-stimulated B cells. Blood 100:4565.
8. Mehta, D. S., A. L. Wurster, M. J. Whitters, D. A. Young, M. Collins, and M. J. Grusby. 2003. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170:4111.
9. a encoded antigens in T cell receptor VβS8.1 chain transgenic mice. EMBO J. 8:719.
10. Held, W., D. Cado, and D. H. Raulet. 1996. Transgenic expression of Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 184:2037.
11. Liu, F., Y. K. Song, and D. Liu. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1258.
12. Wang, G., M. Tschoi, R. Spolski, Y. Lou, K. Ozaki, C. Feng, G. Kim, W. J. Leonard, and P. Hwu. 2003. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63:9016.
13. Piskurich, J. F., K.-I. Lin, Y. Wang, J. P.-Y. Ting, and K. Calame. 2000. BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1:526.
14. Relijc, R., S. D. Wagner, L. J. Peakman, and D. T. Fearon. 2000. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J. Exp. Med. 192:1841.
15. Akilesh, S., D. J. Shaffer, and D. C. Roopenian. 2003. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res. 13:1719.
16. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323.
17. Hao, Z., and K. Rajewsky. 2001. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194:1151.
18. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carseni. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.
19. Sze, D. M., K. M. Toellner, C. Garcia de Vinuesa, D. R. Taylor, and I. C. MacLennan. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813.
20. Calame, K. L., K. I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:205.
21. Gorlick, L., A. H. Cutler, G. Thill, S. D. Miklasz, D. E. Shea, C. Ambrose, S.A. Bixler, L. Su, M. L. Scott, and S. L. Kalled. 2004. BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 172:762.
22. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167:6834.
23. Turner, C. A., Jr., D. H. Mack, and M. M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297.
24. Shaffer, A. L., K. I. Lin, T. C. Kuo, X. Yu, E. M. Hurt, A. Rosenwald, J. M. Giltnane, L. Yang, H. Zhao, K. Calame, and L. M. Staudt. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51.
25. Messika, E. J., P. S. Lu, Y. J. Sung, T. Yaho, J. T. Chi, Y. H. Chien, and M. M. Davis. 1998. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J. Exp. Med. 188:515.
26. Murphy, E. D., and J. B. Roths. 1979. A Y chromosome associated factor in strain BXSB producing accelerated autoimmuniry and lymphoproliteration. Arthritis Rheum. 22:1188.
27. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel. J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221.
28. Pene, J., J. Gauchat, S. Lecart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J. Lecron, and H. Yssel. 2004. IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172:5154.
29. Knodel, M., A. W. Kuss, I. Berberich, and A. Schimpl. 2001. Blimp-1 overexpression abrogates IL-4 and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur. J. Immunol. 31:1972.
30. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701.
31. Brenne, A. T., T. Baade Ro, A. Waage, A. Sundan, M. Borset, and H. Hjorth-Hansen. 2002. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 99:3756.
32. Wofsy, D. 1986. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136:4554.
33. King, C., A. Ilic, K. Koelsch and N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265.